Development and validation of a 19-feature classifier that predicts response to neoadjuvant trastuzumab emtansine (T-DM1) in breast cancer patients Meeting Abstract


Authors: Pareja, F.; Paul, E. D.; Huraiová, B.; Valková, N.; Matyasovská, N.; Gábrisová, D.; Gubová, S.; Ignacáková, H.; Ondris, T.; Bendíková, S.; Lovísek, D.; Gala, M.; Comino-Mendez, I.; Kather, J. N.; Cekan, P.
Abstract Title: Development and validation of a 19-feature classifier that predicts response to neoadjuvant trastuzumab emtansine (T-DM1) in breast cancer patients
Meeting Title: ESMO Congress 2024
Journal Title: Annals of Oncology
Volume: 35
Issue: Suppl. 2
Meeting Dates: 2024 Sept 13-17
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2024-09-01
Start Page: S320
Language: English
ACCESSION: WOS:001326612900248
DOI: 10.1016/j.annonc.2024.08.193
PROVIDER: wos
Notes: Meeting Abstract: 250P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors